報價延遲最少15分鐘:2025/01/21 08:57 EST
|
|
|
|
|
||||||||||||
|
|
|
|
|
-- 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.61/1.00
|
|
企業價值
1.02B
|
| 資產負債 |
|
每股賬面淨值
2.28
|
| 現金流量 |
|
現金流量率
0.05
|
| 損益表 |
|
收益
512.35M
|
|
每股收益
7.69
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/01/21 08:57 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets. |